Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-04

Clinical Trial Update: A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing esreboxetine's effects on concentration, memory, decision making, and problem solving in patients with fibromyalgia; study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • esreboxetine (esreboxetine)

Snippet

Sponsor: Pfizer | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED